Rankings
▼
Calendar
FOLD Q2 2016 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
FOLD
Amicus Therapeutics, Inc.
$5B
Q2 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$49M
Net Income
-$51M
EPS (Diluted)
$-0.40
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$33M
Free Cash Flow
-$34M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$914M
Total Liabilities
$580M
Stockholders' Equity
$334M
Cash & Equivalents
$64M
← FY 2016
All Quarters
Q3 2016 →